The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
802
Pentamidine Aerosol To Prevent Pneumocystis Carinii Pneumonia
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Pentamidine Aerosol To Prevent Pneumocystis Carinii Pneumonia
Pneumocystis carinii pneumonia (PCP) occurs in nearly 80% of patients with the acquired immune deficiency syndrome (AIDS) and is a common cause of morbidity and mortality. Oral trimethoprim-sulfamethoxazole (Bactrim; and others), intravenous ...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Pentamidine Aerosol To Prevent Pneumocystis Carinii Pneumonia
Article code: 802c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.